title: Passive immunotherapeutic strategies for the treatment of malignant gliomas.
abstract: This review provides historical and recent perspectives related to passive immunotherapy for high-grade gliomas. The authors discuss approaches that use lymphokine-activated killer cells, cytotoxic T lymphocytes, and monoclonal antibodies.
authors: Department of Neurosurgery, University of California Los Angeles, Los Angeles, CA 90095-1761, USA.
authors: Daniel T
authors: DT
authors: Nagasawa
authors: Christina
authors: C
authors: Fong
authors: Andrew
authors: A
authors: Yew
authors: Marko
authors: M
authors: Spasic
authors: Heather M
authors: HM
authors: Garcia
authors: Carol A
authors: CA
authors: Kruse
authors: Isaac
authors: I
authors: Yang
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000276:immunology / Q000628:therapy*; D055612:Cytokine-Induced Killer Cells / Q000276:immunology; D005909:Glioblastoma / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007116:Immunization, Passive / Q000379:methods*; D016219:Immunotherapy, Adoptive / Q000379:methods*; D016499:Radioimmunotherapy / Q000379:methods; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D019139:Tumor Escape
chemical_list: D000911:Antibodies, Monoclonal